1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => OpenAccess
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    


























































































































    Pitfalls in the Use of Voxel-Based Morphometry as a Biomarker: Examples from Huntington Disease | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleBrain

  
      
Open Access

  
      
Pitfalls in the Use of Voxel-Based Morphometry as a Biomarker: Examples from Huntington Disease
  
    	
S.M.D. Henley, G.R. Ridgway, R.I. Scahill, S. Klöppel, S.J. Tabrizi, N.C. Fox, J. Kassubek and for the EHDN Imaging Working Group

  
    	
American Journal of Neuroradiology April 2010,  31 (4) 711-719; DOI: https://doi.org/10.3174/ajnr.A1939 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵


    1. Ashburner  J, 
    2. Friston  KJ
    . Voxel-based morphometry: the methods. Neuroimage 2000; 11: 805–21
    CrossRefPubMedWeb of Science
  2. 2.↵


    1. Hirata  Y, 
    2. Matsuda  H, 
    3. Nemoto  K, 
    4. et al
    . Voxel-based morphometry to discriminate early Alzheimer's disease from controls. Neurosci Lett 2005; 382: 269–74
    CrossRefPubMedWeb of Science
  3. 3.↵


    1. Landgrebe  M, 
    2. Binder  H, 
    3. Koller  M, 
    4. et al
    . Design of a placebo-controlled, randomized study of the efficacy of repetitive transcranial magnetic stimulation for the treatment of chronic tinnitus. BMC Psychiatry 2008; 8: 23
    CrossRefPubMed
  4. 4.↵


    1. Teipel  SJ, 
    2. Meindl  T, 
    3. Grinberg  L, 
    4. et al
    . Novel MRI techniques in the assessment of dementia. Eur J Nucl Med Mol Imaging 2008; 3 (suppl 1): S58–S69
  5. 5.↵


    1. Shoulson  I, 
    2. Fahn  S
    . Huntington disease: clinical care and evaluation. Neurology 1979; 29: 1–3
    CrossRef
  6. 6.↵


    Unified Huntington's Disease Rating Scale: reliability and consistency—Huntington Study Group. Mov Disord 1996; 11: 136–42
    CrossRefPubMedWeb of Science
  7. 7.↵


    1. Henley  SM, 
    2. Wild  EJ, 
    3. Hobbs  NZ, 
    4. et al
    . Defective emotion recognition in early HD is neuropsychologically and anatomically generic. Neuropsychologia 2008; 46: 2152–60. Epub 2008 Mar 6
    CrossRefPubMedWeb of Science
  8. 8.↵


    1. Henley  SM, 
    2. Wild  EJ, 
    3. Hobbs  NZ, 
    4. et al
    . Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease. J Neurol 2009; 256: 203–12. Epub 2009 Mar 5
    CrossRefPubMed
  9. 9.↵


    1. Ashburner  J
    . A fast diffeomorphic image registration algorithm. Neuroimage 2007; 38: 95–113. Epub 2007 Jul 18
    CrossRefPubMedWeb of Science
  10. 10.↵


    1. Genovese  CR, 
    2. Lazar  NA, 
    3. Nichols  T
    . Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002; 15: 870–78
    CrossRefPubMedWeb of Science
  11. 11.↵


    1. Good  CD, 
    2. Johnsrude  IS, 
    3. Ashburner  J, 
    4. et al
    . A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001; 14: 21–36
    CrossRefPubMedWeb of Science
  12. 12.↵


    1. Acer  N, 
    2. Sahin  B, 
    3. Bas  O, 
    4. et al
    . Comparison of three methods for the estimation of total intracranial volume: stereologic, planimetric, and anthropometric approaches. Ann Plast Surg 2007; 58: 48–53
    CrossRefPubMed
  13. 13.↵


    1. Good  CD, 
    2. Johnsrude  I, 
    3. Ashburner  J, 
    4. et al
    . Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains. Neuroimage 2001; 14: 685–700
    CrossRefPubMedWeb of Science
  14. 14.↵


    1. Whitwell  JL, 
    2. Crum  WR, 
    3. Watt  HC, 
    4. et al
    . Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. AJNR Am J Neuroradiol 2001; 22: 1483–89
    Abstract/FREE Full Text
  15. 15.↵


    1. Kassubek  J, 
    2. Bernhard  LG, 
    3. Ecker  D, 
    4. et al
    . Global cerebral atrophy in early stages of Huntington's disease: quantitative MRI study. Neuroreport 2004; 15: 363–65
    CrossRefPubMedWeb of Science
  16. 16.↵


    1. Paulsen  JS, 
    2. Magnotta  VA, 
    3. Mikos  AE, 
    4. et al
    . Brain structure in preclinical Huntington's disease. Biol Psychiatry 2006; 59: 57–63
    CrossRefPubMedWeb of Science
  17. 17.↵


    1. Scahill  RI, 
    2. Frost  C, 
    3. Jenkins  R, 
    4. et al
    . A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol 2003; 60: 989–94
    CrossRefPubMedWeb of Science
  18. 18.↵


    1. Kassubek  J, 
    2. Juengling  FD, 
    3. Kioschies  T, 
    4. et al
    . Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry 2004; 75: 213–20
    Abstract/FREE Full Text
  19. 19.↵


    1. Wilke  M, 
    2. Holland  SK, 
    3. Altaye  M, 
    4. et al
    . Template-O-Matic: a toolbox for creating customized pediatric templates. Neuroimage 2008; 41: 903–13. Epub 2008 Mar 8
    CrossRefPubMedWeb of Science
  20. 20.↵


    1. Poldrack  RA, 
    2. Fletcher  PC, 
    3. Henson  RN, 
    4. et al
    . Guidelines for reporting an fMRI study. Neuroimage 2007; 40: 409–14
    PubMed
  21. 21.↵


    1. Ridgway  GR, 
    2. Henley  SM, 
    3. Rohrer  JD, 
    4. et al
    . Ten simple rules for reporting voxel-based morphometry studies. Neuroimage 2008; 40: 1429–35
    CrossRefPubMedWeb of Science
  22. 22.↵


    1. Keller  SS, 
    2. Wilke  M, 
    3. Wieshmann  UC, 
    4. et al
    . Comparison of standard and optimized voxel-based morphometry for analysis of brain changes associated with temporal lobe epilepsy. Neuroimage 2004; 23: 860–68
    CrossRefPubMedWeb of Science
  23. 23.↵


    1. Reimold  M, 
    2. Slifstein  M, 
    3. Heinz  A, 
    4. et al
    . Effect of spatial smoothing on t-maps: arguments for going back from t-maps to masked contrast images. J Cereb Blood Flow Metab 2006; 26: 751–59
    CrossRefPubMedWeb of Science
  24. 24.↵


    1. Mechelli  A, 
    2. Price  CJ, 
    3. Friston  KJ, 
    4. et al
    . Voxel-based morphometry of the human brain: methods and applications. Current Medical Imaging Reviews 2005; 1: 105–113
    CrossRefWeb of Science
  25. 25.↵


    1. Mühlau  M, 
    2. Weindl  A, 
    3. Wohlschlager  AM, 
    4. et al
    . Voxel-based morphometry indicates relative preservation of the limbic prefrontal cortex in early Huntington disease. J Neural Transm 2007; 114: 367–72
    CrossRefPubMedWeb of Science
  26. 26.


    1. Peinemann  A, 
    2. Schuller  S, 
    3. Pohl  C, 
    4. et al
    . Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study. J Neurol Sci 2005; 239: 11–19
    CrossRefPubMedWeb of Science
  27. 27.


    1. Barrios  FA, 
    2. Gonzalez  L, 
    3. Favila  R, 
    4. et al
    . Olfaction and neurodegeneration in HD. Neuroreport 2007; 18: 73–76
    CrossRefPubMedWeb of Science
  28. 28.↵


    1. Fan  Y, 
    2. Resnick  SM, 
    3. Wu  X, 
    4. et al
    . Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study. Neuroimage 2008; 41: 277–85
    CrossRefPubMed
  29. 29.↵


    1. McClure  RK, 
    2. Phillips  I, 
    3. Jazayerli  R, 
    4. et al
    . Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment. Psychiatry Res 2006; 148: 121–32
    CrossRefPubMedWeb of Science
  30. 30.↵


    1. Feigin  A, 
    2. Ghilardi  MF, 
    3. Huang  C, 
    4. et al
    . Preclinical Huntington's disease: compensatory brain responses during learning. Ann Neurol 2006; 59: 53–59
    CrossRefPubMedWeb of Science
  31. 31.↵


    1. Langbehn  DR, 
    2. Brinkman  RR, 
    3. Falush  D, 
    4. et al
    . A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet 2004; 65: 267–77
    CrossRefPubMedWeb of Science
  32. 32.


    1. Thieben  MJ, 
    2. Duggins  AJ, 
    3. Good  CD, 
    4. et al
    . The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 2002; 125: 1815–28
    Abstract/FREE Full Text
  33. 33.


    1. Ho  AK, 
    2. Nestor  PJ, 
    3. Williams  GB, 
    4. et al
    . Pseudo-neglect in Huntington's disease correlates with decreased angular gyrus density. Neuroreport 2004; 15: 1061–64
    CrossRefPubMedWeb of Science
  34. 34.


    1. Kassubek  J, 
    2. Juengling  FD, 
    3. Ecker  D, 
    4. et al
    . Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis. Cereb Cortex 2005; 15: 846–53
    Abstract/FREE Full Text
  35. 35.


    1. Douaud  G, 
    2. Gaura  V, 
    3. Ribeiro  MJ, 
    4. et al
    . Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage 2006; 32: 1562–75
    CrossRefPubMedWeb of Science
  36. 36.


    1. Gavazzi  C, 
    2. Nave  RD, 
    3. Petralli  R, 
    4. et al
    . Combining functional and structural brain magnetic resonance imaging in Huntington disease. J Comput Assist Tomogr 2007; 31: 574–80
    CrossRefPubMedWeb of Science
  37. 37.


    1. Jech  R, 
    2. Klempir  J, 
    3. Vymazal  J, 
    4. et al
    . Variation of selective gray and white matter atrophy in Huntington's disease. Mov Disord 2007; 22: 1783–89
    CrossRefPubMed
  38. 38.


    1. Kipps  CM, 
    2. Duggins  AJ, 
    3. McCusker  EA, 
    4. et al
    . Disgust and happiness recognition correlate with anteroventral insula and amygdala volume respectively in preclinical Huntington's disease. J Cogn Neurosci 2007; 19: 1206–17
    CrossRefPubMedWeb of Science
  39. 39.


    1. Mühlau  M, 
    2. Gaser  C, 
    3. Wohlschlager  AM, 
    4. et al
    . Striatal gray matter loss in Huntington's disease is leftward biased. Mov Disord 2007; 22: 1169–73
    CrossRefPubMedWeb of Science
  40. 40.


    1. Ruocco  HH, 
    2. Bonilha  L, 
    3. Li  LM, 
    4. et al
    . Longitudinal analysis of regional gray matter loss in Huntington disease: effects of the length of the CAG repeat. J Neurol Neurosurg Psychiatry 2007; 79: 130–35
    CrossRefPubMed
  41. 41.


    1. Wolf  RC, 
    2. Vasic  N, 
    3. Schonfeldt-Lecuona  C, 
    4. et al
    . Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. Brain 2007; 130: 2845–57
    Abstract/FREE Full Text
  42. 42.


    1. Wolf  RC, 
    2. Vasic  N, 
    3. Schonfeldt-Lecuona  C, 
    4. et al
    . Cortical dysfunction in patients with Huntington's disease during working memory performance. Hum Brain Mapp 2009; 30: 327–39
    CrossRefPubMedWeb of Science
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Pitfalls in the Use of Voxel-Based Morphometry as a Biomarker: Examples from Huntington Disease
  
    	
S.M.D. Henley, G.R. Ridgway, R.I. Scahill, S. Klöppel, S.J. Tabrizi, N.C. Fox, J. Kassubek, for the EHDN Imaging Working Group

  
    	
 American Journal of Neuroradiology Apr 2010, 31 (4) 711-719; DOI: 10.3174/ajnr.A1939 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement